- Investing Ideas
- Australian Pharmaceuticals & Biotech Healthy potentially undervalued
Australian Pharmaceuticals & Biotech Healthy potentially undervalued
Results
2
0 new
Companies which are potentially undervalued and in an acceptable financial position.
2 companies
Clinuvel Pharmaceuticals
Market Cap: AU$521.9m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$10.35
7D
1.8%
1Y
-0.3%
Radiopharm Theranostics
Market Cap: AU$67.3m
A clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs.
RAD
AU$0.019
7D
-5.0%
1Y
-13.6%